Rifampicin-Mediated Metabolic Changes in <i>Mycobacterium tuberculosis</i>
<i>Mycobacterium tuberculosis (Mtb)</i> is considered to be a devastating pathogen worldwide, affecting millions of people globally. Several drugs targeting distinct pathways are utilized for the treatment of tuberculosis. Despite the monumental efforts being directed at the discovery of...
Main Authors: | Soujanya D. Yelamanchi, Archita Mishra, Santosh Kumar Behra, Gayathree Karthikkeyan, Thottethodi Subrahmanya Keshava Prasad, Avadhesha Surolia |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/12/6/493 |
Similar Items
-
Metabolite Dysregulation by Pranlukast in <i>Mycobacterium tuberculosis</i>
by: Soujanya D. Yelamanchi, et al.
Published: (2022-02-01) -
A Comprehensive Workflow of Mass Spectrometry-Based Untargeted Metabolomics in Cancer Metabolic Biomarker Discovery Using Human Plasma and Urine
by: Jianwen She, et al.
Published: (2013-09-01) -
Metabolomics reveals differences in metabolite profiles between wild and cultivated Tetrastigmae Radix
by: Haijie Chen, et al.
Published: (2024-01-01) -
LC-MS investigated as a tool to study the metabolomic characteristics of cereal fermentation
by: Rishibha Gupta, et al.
Published: (2024-06-01) -
Identification of metabolite biomarkers in Salmonella enteritidis-contaminated chickens using UHPLC-QTRAP-MS-based targeted metabolomics
by: Lan Chen, et al.
Published: (2023-12-01)